DuPont
Makes healthcare, water, building, and industrial materials for demanding applications.
Something off on this page? Send us feedback.
Profile
Sells medical packaging and components, water-filtration systems, building materials, and engineered industrial products through two segments. Its global model combines specialty-product sales with application development and technical support, while the post-Qnity portfolio retains shared legacy PFAS obligations.
Operates through Healthcare & Water Technologies and Diversified Industrials. The first supplies Tyvek medical packaging, protective garments, specialty medical-device components, and reverse-osmosis, ultrafiltration, and ion-exchange products for industrial, municipal, desalination, and life-science water systems. The second sells Tyvek building barriers, Styrofoam insulation, Corian surfaces, Vespel parts, Molykote lubricants, structural adhesives, and Cyrel printing plates.
Serves customers worldwide through direct sales and distributors, with manufacturing across multiple regions. Pairs materials and process technology with application development, specialized manufacturing, and technical testing for regulated or demanding uses. Demand tracks construction, automotive, aerospace, healthcare, and water-treatment activity, while raw-material costs and environmental rules affect operations. Qnity electronics and Kevlar/Nomex aramids are now outside the portfolio; legacy PFAS costs remain subject to sharing arrangements with Chemours and Corteva, with part allocated to Qnity.
Company facts
Key statistics
Year to date +11.7% · Average volume (30d) 1.5M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 5, 2026 | UBS | Reiterate | Buy | $59 | $178 |
| Jun 15, 2026 | Goldman Sachs | Target | $102 | $53 | |
| May 11, 2026 | RBC Capital | Reiterate | Outperform | $56 | $60 |
| May 6, 2026 | UBS | Reiterate | Buy | $56 | $59 |
| Apr 24, 2026 | RBC Capital | Reiterate | Outperform | $161 | $56 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026Q2 FY26 | $1.76 | $1.88 | +6.8% | $1.81B | $1.82B | +0.7% | +1.17% |
| May 5, 2026Q1 FY26 | $0.49 | $1.65 | +238.0% | $1.67B | $1.68B | +0.9% | +1.69% |
| Feb 10, 2026Q4 FY25 | $0.43 | $0.46 | +7.0% | $1.69B | $1.69B | +0.3% | +4.25% |
| Nov 6, 2025Q3 FY25 | $0.47 | $1.09 | +134.1% | $2.90B | $3.07B | +5.9% | +1.66% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $3.07B | $3.26B | $3.07B | $1.69B | $1.68B | $1.82B | |
| Gross profit | $1.00B | $1.08B | $1.07B | $527.0M | $602.0M | $639.0M | |
| Operating income | $494.0M | $529.0M | $547.0M | $227.0M | $186.0M | $256.0M | |
| Net income | −$589.0M | $59.0M | −$123.0M | −$126.0M | $161.0M | $143.0M | |
| Diluted EPS | −$4.23 | $0.42 | −$0.87 | −$0.90 | $1.17 | $1.05 | |
| Gross margin | 32.6% | 33.0% | 35.0% | 31.1% | 35.8% | 35.1% | |
| Operating margin | 16.1% | 16.2% | 17.8% | 13.4% | 11.1% | 14.1% |
Fiscal years (4-quarter sums)FY21 $12.57B · FY22 $13.02B · FY23 $12.07B · FY24 $12.06B · FY25 $11.09B
Revenue by product · FY24
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $1.74B · Total debt $3.13B · Total assets $21.06B · Shareholders' equity $13.77B
Dividends
Raised for 6 straight years — most recently to $0.20 from $0.5145 split-adjusted in Nov 2025. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| May 15, 2026 | May 15 | May 29 | $0.20 | |
| Mar 2, 2026 | Mar 2 | Mar 16 | $0.20 | |
| Nov 28, 2025 | Nov 28 | Dec 15 | $0.20 | raised from $0.5145 split-adjusted |
| Aug 29, 2025 | Aug 29 | Sep 15 | $0.41 | |
| May 30, 2025 | May 30 | Jun 16 | $0.41 | |
| Mar 3, 2025 | Mar 3 | Mar 17 | $0.41 | raised from $0.38 |
| Nov 29, 2024 | Nov 29 | Dec 16 | $0.38 | |
| Aug 30, 2024 | Aug 30 | Sep 16 | $0.38 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 135.02M · Float 134.51M · 99.6% free float
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.64M | 7.88% | 13F | Aug 7, 2026 |
| Vanguard Capital Management LLC | 8.94M | 6.62% | 13F | Aug 13, 2026 |
| State Street Corporation | 6.96M | 5.10% | 13G | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 6.41M | 4.74% | 13F | Aug 13, 2026 |
| Invesco Ltd. | 3.79M | 2.81% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 2, 2026 | Lori Koch | director, officer: CEO | −261 | $48.82 |
| Nov 28, 2025 | Lori Koch | director, officer: CEO | −9,011 | $39.46 |
| Nov 28, 2025 | Erik T. Hoover | officer: SVP & General Counsel | −6,005 | $39.79 |
| Sep 15, 2025 | Steven P. Larrabee | officer: SVP & CIO | −43,208 | $77.17 |
| Sep 5, 2025 | Steven P. Larrabee | officer: SVP & CIO | −6,000 | $78.00 |
Peers
- Danaher
Filtration and bioprocessing platforms challenge water and Liveo uses.
- Pentair
Water filtration and treatment systems overlap with DuPont Water.
- Owens Corning
Insulation and building-envelope products contest construction channels.
- 3M
Industrial adhesives, films, safety and advanced materials overlap.
- Amcor
Healthcare and pharmaceutical packaging overlap with Tyvek.
- Ecolab
Industrial water programs and Purolite resins pressure water technologies.
- Eastman Chemical
Specialty plastics, films and additives overlap in industrial materials.
- Parker-Hannifin
Engineered materials and filtration overlap in industrial applications.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| DuPont | $136.98 | −0.01% | $18.49B | 304.4 | 18.2 | 2.2 | −44.2% |
| Danaher | $215.50 | −0.25% | $151.89B | 38.4 | 24.3 | 6.0 | +5.5% |
| Pentair | $61.28 | −0.67% | $9.84B | 15.5 | 12.7 | 2.5 | −17.0% |
| Owens Corning | $143.13 | −0.03% | $11.53B | — | 13.0 | 1.2 | +0.3% |
| 3M | $174.82 | +0.27% | $89.91B | 31.0 | 18.8 | 3.6 | +2.5% |
| Amcor | $46.80 | +0.28% | $21.58B | 19.6 | 10.7 | 0.9 | +25.9% |
| Ecolab | $275.05 | −4.11% | $80.70B | 38.5 | 33.2 | 4.8 | +9.7% |
| Eastman Chemical | $73.03 | 0.00% | $8.35B | 19.0 | 10.8 | 0.9 | +9.7% |
| Parker-Hannifin | $996.00 | +0.11% | $125.46B | 34.9 | 28.3 | 5.8 | +9.8% |
| Median | 31.0 | 15.9 | 3.0 | +7.6% |